BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19808342)

  • 1. Predictors of heart failure in patients with stable coronary artery disease: a PEACE study.
    Lewis EF; Solomon SD; Jablonski KA; Rice MM; Clemenza F; Hsia J; Maggioni AP; Zabalgoitia M; Huynh T; Cuddy TE; Gersh BJ; Rouleau J; Braunwald E; Pfeffer MA;
    Circ Heart Fail; 2009 May; 2(3):209-16. PubMed ID: 19808342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.
    Omland T; Sabatine MS; Jablonski KA; Rice MM; Hsia J; Wergeland R; Landaas S; Rouleau JL; Domanski MJ; Hall C; Pfeffer MA; Braunwald E;
    J Am Coll Cardiol; 2007 Jul; 50(3):205-14. PubMed ID: 17631211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of angiotensin-converting enzyme inhibitors on clinical outcomes in patients with ischemic cardiomyopathy and midrange ejection fraction: a post hoc subgroup analysis from the PEACE trial.
    Alzahrani T; Tiu J; Panjrath G; Solomon A
    Ther Adv Cardiovasc Dis; 2018 Dec; 12(12):351-359. PubMed ID: 30442080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of new-onset refractory congestive heart failure using gated myocardial perfusion SPECT imaging in patients with known or suspected coronary artery disease subanalysis of the J-ACCESS database.
    Nakata T; Hashimoto A; Wakabayashi T; Kusuoka H; Nishimura T
    JACC Cardiovasc Imaging; 2009 Dec; 2(12):1393-400. PubMed ID: 20083074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sudden cardiac death in patients with stable coronary artery disease and preserved left ventricular systolic function.
    Hsia J; Jablonski KA; Rice MM; Sabatine MS; Zabalgoitia M; Maggioni A; Cuddy TE; Domanski MJ; Geller NL; Flaker G; Solomon S; Omland T; Rouleau JL;
    Am J Cardiol; 2008 Feb; 101(4):457-61. PubMed ID: 18312757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and Long-Term Survival After Coronary Artery Bypass Grafting in Women and Men With Heart Failure and Preserved Versus Reduced Ejection Fraction.
    Sun LY; Tu JV; Bader Eddeen A; Liu PP
    J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29909401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simple integer risk score to determine prognosis of patients with hypertension and chronic stable coronary artery disease.
    Bavry AA; Kumbhani DJ; Gong Y; Handberg EM; Cooper-Dehoff RM; Pepine CJ
    J Am Heart Assoc; 2013 Aug; 2(4):e000205. PubMed ID: 23948642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angs (Angiotensins) of the Alternative Renin-Angiotensin System Predict Outcome in Patients With Heart Failure and Preserved Ejection Fraction.
    Binder C; Poglitsch M; Agibetov A; Duca F; Zotter-Tufaro C; Nitsche C; Aschauer S; Kammerlander AA; Oeztuerk B; Hengstenberg C; Mascherbauer J; Bonderman D
    Hypertension; 2019 Aug; 74(2):285-294. PubMed ID: 31230551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting-enzyme inhibition in stable coronary artery disease.
    Braunwald E; Domanski MJ; Fowler SE; Geller NL; Gersh BJ; Hsia J; Pfeffer MA; Rice MM; Rosenberg YD; Rouleau JL;
    N Engl J Med; 2004 Nov; 351(20):2058-68. PubMed ID: 15531767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
    Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction: The Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) Trial.
    Solomon SD; Claggett B; Desai AS; Packer M; Zile M; Swedberg K; Rouleau JL; Shi VC; Starling RC; Kozan Ö; Dukat A; Lefkowitz MP; McMurray JJ
    Circ Heart Fail; 2016 Mar; 9(3):e002744. PubMed ID: 26915374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial.
    Solomon SD; Rice MM; A Jablonski K; Jose P; Domanski M; Sabatine M; Gersh BJ; Rouleau J; Pfeffer MA; Braunwald E;
    Circulation; 2006 Jul; 114(1):26-31. PubMed ID: 16801465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discharge treatment with angiotensin-converting enzyme inhibitor/angiotensin receptor blocker after a heart failure hospitalisation is associated with a better prognosis irrespective of left ventricular ejection fraction.
    Vicent L; Cinca J; Vazquez-García R; Gonzalez-Juanatey JR; Rivera M; Segovia J; Pascual-Figal D; Bover R; Worner F; Delgado-Jiménez J; Fernández-Avilés F; Martínez-Sellés M
    Intern Med J; 2019 Dec; 49(12):1505-1513. PubMed ID: 30887642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypotheses, rationale, design, and methods for prognostic evaluation of a randomized comparison between patients with coronary artery disease associated with ischemic cardiomyopathy who undergo medical or surgical treatment: MASS-VI (HF).
    Rezende PC; Hueb W; Bocchi EA; Farkouh M; Junior CVS; Lima EG; Silva EER; Dallan LAO; Gaiotto FA; Garzillo CL; Rochitte CE; Nomura CH; Scudeler TL; Soares PR; Jatene FB; Ramires JAF; Filho RK
    Trials; 2020 Apr; 21(1):337. PubMed ID: 32299458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial.
    Solomon SD; Rizkala AR; Lefkowitz MP; Shi VC; Gong J; Anavekar N; Anker SD; Arango JL; Arenas JL; Atar D; Ben-Gal T; Boytsov SA; Chen CH; Chopra VK; Cleland J; Comin-Colet J; Duengen HD; Echeverría Correa LE; Filippatos G; Flammer AJ; Galinier M; Godoy A; Goncalvesova E; Janssens S; Katova T; Køber L; Lelonek M; Linssen G; Lund LH; O'Meara E; Merkely B; Milicic D; Oh BH; Perrone SV; Ranjith N; Saito Y; Saraiva JF; Shah S; Seferovic PM; Senni M; Sibulo AS; Sim D; Sweitzer NK; Taurio J; Vinereanu D; Vrtovec B; Widimský J; Yilmaz MB; Zhou J; Zweiker R; Anand IS; Ge J; Lam CSP; Maggioni AP; Martinez F; Packer M; Pfeffer MA; Pieske B; Redfield MM; Rouleau JL; Van Veldhuisen DJ; Zannad F; Zile MR; McMurray JJV
    Circ Heart Fail; 2018 Jul; 11(7):e004962. PubMed ID: 29980595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-Blockers and Cardiovascular Outcomes in Acute Heart Failure with a History of Coronary Artery Disease and an Ejection Fraction ≥ 40.
    Abi Khalil C; Sulaiman K; Asaad N; AlHabib KF; Alsheikh-Ali A; Jameesh M; Al-Jarallah M; Bulbanat B; AlMahmeed W; Ridha M; Bazargani N; Amin H; Al-Motarreb A; AlFaleh H; Panduranga P; Mahfoud Z; Al Suwaidi J
    Curr Vasc Pharmacol; 2020; 18(6):644-651. PubMed ID: 31889498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving endothelial function and reducing remodeling post-MI are key to perindopril benefits in coronary artery disease.
    Cardiovasc J S Afr; 2006; 17(4):203-4. PubMed ID: 17001425
    [No Abstract]   [Full Text] [Related]  

  • 18. Multistate Model to Predict Heart Failure Hospitalizations and All-Cause Mortality in Outpatients With Heart Failure With Reduced Ejection Fraction: Model Derivation and External Validation.
    Upshaw JN; Konstam MA; Klaveren Dv; Noubary F; Huggins GS; Kent DM
    Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27514751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renin-angiotensin system blockade reduces cardiovascular events in nonheart failure, stable patients with prior coronary intervention.
    Choi Y; Lim S; Lee KY; Park HW; Byeon J; Hwang BH; Kim JJ; Oh YS; Youn HJ; Jung WS; Seung KB; Chang K
    Coron Artery Dis; 2018 Sep; 29(6):451-458. PubMed ID: 29489465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of adverse outcome among patients with hypertension and coronary artery disease.
    Pepine CJ; Kowey PR; Kupfer S; Kolloch RE; Benetos A; Mancia G; Coca A; Cooper-DeHoff RM; Handberg E; Gaxiola E; Sleight P; Conti CR; Hewkin AC; Tavazzi L;
    J Am Coll Cardiol; 2006 Feb; 47(3):547-51. PubMed ID: 16458134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.